Understanding – and increasing – calcium signaling could lead to new therapeutic strategies for age-associated inflammation. Researchers have discovered a …
Continue reading “Inflammaging discovery could slow aging and prevent age-related diseases”
Protein found in bats could tackle inflammation – and aging. In the quest to unlock the secrets of aging, scientists …
Senescent cells promote NAD tissue decline during aging through CD38 enzymes which can now become a novel therapeutic target. Nicotinamide …
Continue reading “NAD boosting to reverse senescence and inflammaging”
Avenna claims the first reliable, quantitative biomarkers for subclinical systemic chronic inflammation. Using the science of glycomics, British start-up Avenna …
Keystone Bio seeks funding as it gears up for clinical trials of therapeutic targeting the “keystone pathogen” of chronic inflammaging. …
Continue reading “Targeting inflammaging: the hidden “inflammapath” inside us”
Neurodegenerative disease is associated with age-related chronic, low grade inflammation, but studies suggest that this could be reversed with over …
Continue reading “Inflammaging – could ibuprofen be the answer?”
One of the largest deals in Irish biotech history sees Roche gain rights to full Inflazome portfolio. The Swiss company …
Continue reading “Inflammaging biotech acquired by Roche for €380m”
Researchers use metformin to repair broken cell machinery and drastically lower dangerous inflammation. Inflammaging is one of the latest Longevity …
Continue reading “Metformin boost for inflammaging research”
Clinical-stage immunotherapy company HCW Biologics (NASDAQ: HCWB) was granted a new US patent which contains methods of use claims directed …
Continue reading “HCW Biologics lands US patent with senotherapeutic potential”
